- Home
- CNTX
as 07-26-2024 4:00pm EST
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | PHILADELPHIA |
| Market Cap: | 149.2M | IPO Year: | 2021 |
| Target Price: | $6.50 | AVG Volume (30 days): | 104.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.77 - $2.54 | Next Earning Date: | 08-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Context Therapeutics Inc. News
CNTX Breaking Stock News: Dive into CNTX Ticker-Specific Updates for Smart Investing
MT Newswires
16 days ago
Context Therapeutics Acquires T-cell Engager CT-95 From Link
GlobeNewswire
17 days ago
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
Zacks
a month ago
Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
MT Newswires
2 months ago
Context Therapeutics Files Prospectus for Secondary Offering
Zacks
2 months ago
Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice
Zacks
2 months ago
Context Therapeutics Inc. (CNTX) Upgraded to Buy: Here's Why
GlobeNewswire
3 months ago
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire
3 months ago
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
Compare CNTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNTX Context Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.